Ignyta To Chair The Institute Of Medicine’s National Cancer Policy Forum Workshop On Molecularly Targeted Cancer Therapies

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced that its Chief Medical Officer, Adrian Senderowicz, M.D., has been selected to serve as Workshop Planning Committee Chair for the workshop entitled Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer. The event will be hosted by the Institute of Medicine’s National Cancer Policy Forum on November 10 and 11, 2014 at the Keck Center of the National Academies in Washington, D.C.

Help employers find you! Check out all the jobs and post your resume.

Back to news